December 6, 2024 - 03:20

Chinese digital content provider Jinxin Technology has unveiled the terms of its upcoming initial public offering (IPO), planning to offer 1.25 million American Depositary Shares (ADSs) priced at $4.00 each. The company is set to trade under the ticker symbol NAMI on the Nasdaq stock exchange.
This strategic move aims to raise approximately $5 million, which will be directed towards various growth initiatives within the company. Jinxin Technology focuses on the development and distribution of digital content, catering to a rapidly growing market that increasingly relies on online platforms for entertainment and information.
With the IPO scheduled for December, Jinxin Technology is positioning itself to capitalize on the expanding digital landscape. The funds generated from this offering are expected to enhance its operational capabilities and support further innovations in digital content creation and distribution. Investors will be closely watching the debut as the company enters the competitive public market.
April 24, 2026 - 04:02
Next Technology Drive Construction to Cause Weekend Traffic Disruptions in MadisonMADISON, AL – Motorists in Madison should prepare for significant traffic disruptions along Next Technology Drive this weekend as construction crews begin a new phase of roadway improvements. The...
April 23, 2026 - 00:48
AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICERAmgen has announced the retirement of Dr. David M. Reese, the company`s Executive Vice President and Chief Technology Officer. The decision is effective as of the end of this year, concluding a...
April 22, 2026 - 12:12
Japan lowers restrictions on weapon and technology exportsIn a historic policy shift, the Japanese government has approved a sweeping revision to its strict defense export controls, effectively lifting a decades-long ban on selling lethal weapons abroad....
April 21, 2026 - 17:12
Technology Guide: Modern cellular analysis in early drug discoveryThe initial stages of drug discovery are being transformed by a new generation of cellular analysis technologies. By moving beyond traditional, one-dimensional assays, scientists are now able to...